Dachaigh › Cancer Ovarian › Maryland › Baltimore
Sgrùdaidhean clionaigeach Cancer Ovarian ann an Baltimore, MD
Tha 22 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann agus timcheall air Baltimore (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
A’ fastadhÌre 2/3
- University of Maryland/Greenebaum Cancer Center, Baltimore
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A’ fastadhÌre 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 2
- Johns Hopkins University, Baltimore
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
A’ fastadhÌre 3
- Research Site, Baltimore
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A’ fastadhÌre 2
- University of Maryland, Baltimore /ID# 275308, Baltimore
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A’ fastadhÌre 3
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital Of Baltimore, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A’ fastadhÌre 1
- United Theranostics, Glen Burnie · 9 mìle air falbh
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A’ fastadhÌre 2
- Greater Baltimore Medical Center, Baltimore
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
A’ fastadhÌre 1/2
- Research Site, Baltimore
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
A’ fastadhÌre 3
- Greater Baltimore Medical Center, Towson · 8 mìle air falbh
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A’ fastadhÌre 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
A’ fastadhÌre 2
- The John Hopkins Hospital, Baltimore
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
A’ fastadhÌre 3
- University of Maryland, Baltimore
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
A’ fastadhÌre 3
- Greater Baltimore Medical Center, Towson · 8 mìle air falbh
EXoPERT EMERALD Clinical Study
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- John Hopkins University, Baltimore
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
A’ fastadhÌre 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A’ fastadhÌre 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
A’ fastadhÌre 2
- SCRI - Maryland Oncology Hematology, P.A., Annapolis · 22 mìle air falbh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mìle air falbh
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
A’ fastadhÌre 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
A’ fastadhSgrùdadh amharc
- Johns Hopkins University School of Medicine, Baltimore
- Anne Arundel Health System, Annapolis · 22 mìle air falbh
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
A’ fastadhÌre 1/2
- Johns Hopkins, Baltimore
Sgrùdaidhean Cancer Ovarian ann am bailtean eile
- Houston, TX89 sgrùdaidhean
- New York City, NY69 sgrùdaidhean
- Boston, MA61 sgrùdaidhean
- Los Angeles, CA50 sgrùdaidhean
- Nashville, TN49 sgrùdaidhean
- Arlington, VA46 sgrùdaidhean
- Philadelphia, PA44 sgrùdaidhean
- Columbus, OH39 sgrùdaidhean
- St. Louis, MO38 sgrùdaidhean
- Chicago, IL36 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Cleveland, OH30 sgrùdaidhean
Sgrùdaidhean eile ann an Baltimore
- Aillse Sgamhain Neo-chealla-beag60 sgrùdaidhean
- Aillse a' bhroilleach47 sgrùdaidhean
- Aillse Prostata43 sgrùdaidhean
- Ailseachadh nan Sgamhan40 sgrùdaidhean
- Aillse (gach seòrsa)37 sgrùdaidhean
- Cancer Pancreatic31 sgrùdaidhean
- Aillse colorectal31 sgrùdaidhean
- Ailse metastatach28 sgrùdaidhean
- Obesity26 sgrùdaidhean
- Aillse sa bhlaire24 sgrùdaidhean
- Fàilligeadh a' Chridhe24 sgrùdaidhean
- Buailteach21 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.